Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 2, 2013, Pages 153-161

  Gray, Elizabeth ^a   Rice, Claire ^a   Nightingale, Helen ^a   Ginty, Mark ^a   Hares, Kelly ^a   Kemp, Kevin ^a   Cohen, Nicki ^a   Love, Seth ^a   Scolding, Neil ^a   Wilkins, Alastair ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

demyelinated cortex; Hyperphosphorylated; neurodegeneration; neurofilament

Indexed keywords

BIOLOGICAL MARKER; NEUROFILAMENT H PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY LABELING; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; PERIKARYON; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS;

EID: 84870999501     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512451661     Document Type: Article

References (36)

1. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain. 2000 ; 123 (Pt 6). 1174-1183
2. Ferguson B, Matyszak MK, et al. Axonal damage in acute multiple sclerosis lesions. Brain. 1997 ; 120 (Pt 3). 393-399
3. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 ; 132: 1175-1189
4. Schirmer L, Albert M, Buss A, et al. Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Ann Neurol. 2009 ; 66: 698-704
5. Siffrin V, Vogt J, Radbruch H, et al. Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci. 2010 ; 33: 202-210
6. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 ; 338: 278-285
7. Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 2002 ; 52: 650-653
8. Gilmore CP, DeLuca GC, Bo L, et al. Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol. 2009 ; 19: 642-649
9. Papadopoulos D, Dukes S, Patel R, et al. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 2009 ; 19: 238-253
10. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005 ; 64: 1101-1107
11. Vogt J, Paul F, Aktas O, et al. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol. 2009 ; 66: 310-322
12. Wegner C, Esiri MM, Chance SA, et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology. 2006 ; 67: 960-967
13. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol. 2004 ; 58: 131-148
14. Shea TB, Jung C, Pant HC. Does neurofilament phosphorylation regulate axonal transport?. Trends Neurosci. 2003 ; 26: 397-400
15. Sternberger LA, Sternberger NH. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci U S A. 1983 ; 80: 6126-6130
16. Bo L MAGNIMS Clinically Isolated Syndrome Workshop. Miller DH FM Thompson AJ, ed. 2004 :
17. Petzold A, Gveric D, Groves M, et al. Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology. Exp Neurol. 2008 ; 213: 326-335
18. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005 ; 233: 183-198
19. Sternberger NH, Sternberger LA, Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci U S A. 1985 ; 82: 4274-4276
20. Pollanen MS, Bergeron C, Weyer L. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments. Acta Neuropathol. 1994 ; 88: 1-6
21. Manetto V, Sternberger NH, Perry G, et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1988 ; 47: 642-653
22. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001 ; 50: 389-400
23. Vercellino M, Masera S, Lorenzatti M, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol. 2009 ; 68: 489-502
24. Vercellino M, Merola A, Piacentino C, et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol. 2007 ; 66: 732-739
25. Cork LC, Sternberger NH, Sternberger LA, et al. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol. 1986 ; 45: 56-64
26. Forno LS, Sternberger LA, Sternberger NH, et al. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett. 1986 ; 64: 253-258
27. Munoz DG, Greene C, et al. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol. 1988 ; 47: 9-18
28. Sobue G, Hashizume Y, Yasuda T, et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol. 1990 ; 79: 402-408
29. Zhang H, Sternberger NH, Rubinstein LJ, et al. Abnormal processing of multiple proteins in Alzheimer disease. Proc Natl Acad Sci U S A. 1989 ; 86: 8045-8049
30. Petzold A, Eikelenboom MJ, Keir G, et al. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry. 2005 ; 76: 206-211
31. Schirmer L, Antel JP, et al. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol. 2011 ; 21: 428-440
32. Petzold A, Tozer DJ, Schmierer K. Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter. Exp Neurol. 2011 ; 232: 234-239
33. Klosen P, Anderton BH, et al. Perikaryal neurofilament phosphorylation in axotomized and 6-OH-dopamine-lesioned CNS neurons. Brain Res. 1990 ; 526: 259-269
34. Shea TB, Chan WK. Regulation of neurofilament dynamics by phosphorylation. Eur J Neurosci. 2008 ; 27: 1893-1901
35. Sobottka B, Harrer MD, Ziegler U, et al. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol. 2009 ; 175: 1160-1166
36. Kreutzer M, Seehusen F, Kreutzer R, et al. Axonopathy Is Associated with Complex Axonal Transport Defects in a Model of Multiple Sclerosis. Brain Pathol. 2011 ;: